Zdrowie i gospodarka · 11/05/2022

FDA Renews Gastrointestinal Drugs Advisory Committee for 2 Years

The FDA has renewed the Gastrointestinal Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on March 3, 2024, following a determination by the Commissioner of Food and Drugs that it is in the public interest to do so.